Sanofi to acquire Principia Biopharma

The late-stage biopharmaceutical company focused on developing treatments for immune-mediated diseases has entered into a definitive agreement with Sanofi

picture of

Breaking News

FairJourney enters antibody discovery agreement with Pandion

Pandion focuses on the development of modular therapeutics using its Talon (Therapeutic Autoimmune reguLatOry proteiN) ...

Lonza and Be The Match BioTherapies partner on CGT

The partnership will build on previous collaborations made by both companies

Pharming to build downstream processing facility in Oss

The facility will process the starting material for the company’s Ruconest product

Royal Society of Chemistry calls for R&D investment

The UK has fallen behind cohort nations in R&D investment, hampering efforts to boost productivity – with the impact ...

Cambrex investing $50m at Charles City API facility

In 2019, Cambrex was acquired by funds advised by Permira, a global investment firm

SGS increases its capacity for human challenges studies

The company has 47 offices and laboratories with 3,600 employees, of which 600 work in the life sciences sector

Beximco Pharma: The Bangladeshi company connecting with the US

COO Rabbur Reza talks about the strategy behind approaching pharmaceutical manufacturing from an emerging market

Lonza expands HPAPI development and manufacturing in Tampa

The company has invested more than $15m to expand and upgrade the Tampa site capabilities over the last two years

Almac receives grant to accelerate COVID-19 treatment manufacture

This news comes six months after Almac announced it was supporting two COVID-19 clinical studies in Sub-Saharan Africa

The experiment: human versus machine

In this article Miha Možina, PhD, Business Developer at Sensum discusses why he believes investment decisions should ...

Addressing the need for cost-effective vaccine manufacturing

Process intensification and integrated continuous bioprocessing are two approaches that can be used to achieve cost- ...

BioCity predicts proliferation of workspace amid life science ventures boom

The UK's life science incubator has released the Life Science Start-Up Report with in-depth analysis of emerging ...

Lead Pharma enters research collaboration with Roche

Under the terms of the agreement, Lead Pharma will receive an upfront payment of $8.44m

Onyx Scientific makes $3.96m UK facility investment

The facility is expected to be approximately 30,000 sqft and will be used for non-GMP & GMP Phase I – III and ...